ICIs targeting cytotoxic T lymphocyte-associated 4 (CTLA-4), programmed cell death protein 1 (PD-1), and PD ligand 1 (PD-L1) inhibit their activity to stop cancer cells from escaping T-cell-mediated death [1]. Here, PDCD1 is linked to cancer.